The Role of Prostaglandin Pathway and EP Receptors in Skin Cancer Development

Emerging therapies, including combination strategies with immune checkpoint inhibitors, highlight the potential of precision medicine approaches to optimize the treatment and prevention of skin cancers, including melanoma.